• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓展全球卫生系统建议的证据基础:优化孕产妇和新生儿健康指南制定过程的优势与挑战

Expanding the evidence base for global recommendations on health systems: strengths and challenges of the OptimizeMNH guidance process.

作者信息

Glenton Claire, Lewin Simon, Gülmezoglu Ahmet Metin

机构信息

Global Health Unit, Knowledge Centre for the Health Services, Norwegian Institute of Public Health, Oslo, Norway.

Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.

出版信息

Implement Sci. 2016 Jul 18;11:98. doi: 10.1186/s13012-016-0470-y.

DOI:10.1186/s13012-016-0470-y
PMID:27430879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4950654/
Abstract

BACKGROUND

In 2012, the World Health Organization (WHO) published recommendations on the use of optimization or "task-shifting" strategies for key, effective maternal and newborn interventions (the OptimizeMNH guidance). When making recommendations about complex health system interventions such as task-shifting, information about the feasibility and acceptability of interventions can be as important as information about their effectiveness. However, these issues are usually not addressed with the same rigour. This paper describes our use of several innovative strategies to broaden the range of evidence used to develop the OptimizeMNH guidance. In this guidance, we systematically included evidence regarding the acceptability and feasibility of relevant task-shifting interventions, primarily using qualitative evidence syntheses and multi-country case study syntheses; we used an approach to assess confidence in findings from qualitative evidence syntheses (the Grading of Recommendations, Assessment, Development and Evaluation-Confidence in Evidence from Reviews of Qualitative Research (GRADE-CERQual) approach); we used a structured evidence-to-decision framework for health systems (the DECIDE framework) to help the guidance panel members move from the different types of evidence to recommendations.

RESULTS

The systematic inclusion of a broader range of evidence, and the use of new guideline development tools, had a number of impacts. Firstly, this broader range of evidence provided relevant information about the feasibility and acceptability of interventions considered in the guidance as well as information about key implementation considerations. However, inclusion of this evidence required more time, resources and skills. Secondly, the GRADE-CERQual approach provided a method for indicating to panel members how much confidence they should place in the findings from the qualitative evidence syntheses and so helped panel members to use this qualitative evidence appropriately. Thirdly, the DECIDE framework gave us a structured format in which we could present a large and complex body of evidence to panel members and end users. The framework also prompted the panel to justify their recommendations, giving end users a record of how these decisions were made.

CONCLUSIONS

By expanding the range of evidence assessed in a guideline process, we increase the amount of time and resources required. Nevertheless, the WHO has assessed the outputs of this process to be valuable and is currently repeating the approach used in OptimizeMNH in other guidance processes.

摘要

背景

2012年,世界卫生组织(WHO)发布了关于在关键、有效的孕产妇和新生儿干预措施中使用优化或“任务转移”策略的建议(《优化孕产妇和新生儿保健指南》)。在就诸如任务转移等复杂的卫生系统干预措施提出建议时,有关干预措施可行性和可接受性的信息与有关其有效性的信息同样重要。然而,这些问题通常没有得到同等严格的处理。本文描述了我们如何运用多种创新策略来拓宽用于制定《优化孕产妇和新生儿保健指南》的证据范围。在本指南中,我们系统地纳入了有关相关任务转移干预措施的可接受性和可行性的证据,主要采用定性证据综合分析和多国案例研究综合分析;我们采用了一种方法来评估定性证据综合分析结果的可信度(推荐分级、评估、制定与评价——定性研究综述证据的可信度(GRADE-CERQual)方法);我们使用了一个针对卫生系统的结构化证据到决策框架(DECIDE框架)来帮助指南制定小组的成员从不同类型的证据得出建议。

结果

系统地纳入更广泛的证据范围以及使用新的指南制定工具产生了多方面的影响。首先,这一更广泛的证据范围提供了有关指南中所考虑干预措施的可行性和可接受性的相关信息以及有关关键实施考量的信息。然而,纳入这些证据需要更多的时间、资源和技能。其次,GRADE-CERQual方法提供了一种向小组成员表明他们应对定性证据综合分析结果抱有多大信心的方法,从而帮助小组成员恰当地使用这些定性证据。第三,DECIDE框架为我们提供了一种结构化的形式,我们可以用这种形式向小组成员和最终用户展示大量复杂的证据。该框架还促使小组为其建议提供理由,为最终用户提供这些决策是如何做出的记录。

结论

通过在指南制定过程中扩大评估的证据范围,我们增加了所需的时间和资源量。尽管如此,WHO已评估该过程的产出具有价值,并且目前正在其他指南制定过程中重复《优化孕产妇和新生儿保健指南》中使用的方法。

相似文献

1
Expanding the evidence base for global recommendations on health systems: strengths and challenges of the OptimizeMNH guidance process.拓展全球卫生系统建议的证据基础:优化孕产妇和新生儿健康指南制定过程的优势与挑战
Implement Sci. 2016 Jul 18;11:98. doi: 10.1186/s13012-016-0470-y.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Qualitative Evidence Synthesis (QES) for Guidelines: Paper 3 - Using qualitative evidence syntheses to develop implementation considerations and inform implementation processes.定性证据综合 (QES) 指南:第 3 篇——利用定性证据综合来制定实施注意事项并为实施过程提供信息。
Health Res Policy Syst. 2019 Aug 8;17(1):74. doi: 10.1186/s12961-019-0450-1.
4
Are we entering a new era for qualitative research? Using qualitative evidence to support guidance and guideline development by the World Health Organization.我们是否正在进入定性研究的新时代?利用定性证据支持世界卫生组织的指南和标准制定。
Int J Equity Health. 2018 Sep 24;17(1):126. doi: 10.1186/s12939-018-0841-x.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series.应用 GRADE-CERQual 对定性证据综合研究结果进行评估:简介系列。
Implement Sci. 2018 Jan 25;13(Suppl 1):2. doi: 10.1186/s13012-017-0688-3.
7
Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 7: understanding the potential impacts of dissemination bias.应用 GRADE-CERQual 对定性证据综合研究结果进行评估 - 第 7 篇:了解传播偏倚的潜在影响。
Implement Sci. 2018 Jan 25;13(Suppl 1):12. doi: 10.1186/s13012-017-0694-5.
8
Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 3: how to assess methodological limitations.应用 GRADE-CERQual 对定性证据综合研究结果进行评估-第 3 部分:如何评估方法学局限性。
Implement Sci. 2018 Jan 25;13(Suppl 1):9. doi: 10.1186/s13012-017-0690-9.
9
Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 - Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements.指南的定性证据综合(QES):第 1 篇——使用定性证据综合来为指南范围提供信息并制定定性发现陈述。
Health Res Policy Syst. 2019 Aug 8;17(1):76. doi: 10.1186/s12961-019-0467-5.
10
Applying GRADE-CERQual to qualitative evidence synthesis findings-paper 2: how to make an overall CERQual assessment of confidence and create a Summary of Qualitative Findings table.应用 GRADE-CERQual 对定性证据综合研究结果进行评估——第 2 部分:如何对信心进行全面的 CERQual 评估并创建定性研究结果总结表。
Implement Sci. 2018 Jan 25;13(Suppl 1):10. doi: 10.1186/s13012-017-0689-2.

引用本文的文献

1
Evaluating the impact of the global evidence, local adaptation (GELA) project for enhancing evidence-informed guideline recommendations for newborn and young child health in three African countries: a mixed-methods protocol.评估全球证据、地方适应(GELA)项目对增强三个非洲国家新生儿和幼儿健康循证指南建议的影响:一项混合方法研究方案。
Health Res Policy Syst. 2024 Aug 19;22(1):114. doi: 10.1186/s12961-024-01189-5.
2
"Going into the black box": a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations.“进入黑箱”:世界卫生组织如何利用证据为指南建议提供信息的政策分析。
Front Public Health. 2024 Mar 22;12:1292475. doi: 10.3389/fpubh.2024.1292475. eCollection 2024.
3
A Perspective on Implementation Outcomes and Strategies to Promote the Uptake of COVID-19 Vaccines.关于促进新冠疫苗接种的实施成果与策略的观点
Front Health Serv. 2022 May 20;2:897227. doi: 10.3389/frhs.2022.897227. eCollection 2022.
4
Evidence-informed decision about (de-)implementing return-to-work coordination to reduce sick leave: a case study.基于证据的(取消/实施)重返工作岗位协调以减少病假的决策:案例研究。
Health Res Policy Syst. 2022 Feb 14;20(1):19. doi: 10.1186/s12961-022-00823-4.
5
The challenge of equipoise in trials with a surgical and non-surgical comparison: a qualitative synthesis using meta-ethnography.具有手术和非手术比较的试验中的均衡挑战:使用荟萃元分析的定性综合。
Trials. 2021 Oct 7;22(1):678. doi: 10.1186/s13063-021-05403-5.
6
Evaluation of the reporting quality of clinical practice guidelines on gliomas using the RIGHT checklist.使用RIGHT清单评估胶质瘤临床实践指南的报告质量。
Ann Transl Med. 2021 Jun;9(12):1002. doi: 10.21037/atm-21-2604.
7
Users' experiences with an interactive Evidence to Decision (iEtD) framework: a qualitative analysis.用户对交互式证据决策 (iEtD) 框架的体验:定性分析。
BMC Med Inform Decis Mak. 2021 May 25;21(1):169. doi: 10.1186/s12911-021-01532-8.
8
An exploration of how developers use qualitative evidence: content analysis and critical appraisal of guidelines.开发者如何使用定性证据的探索:对指南的内容分析和批判性评价。
BMC Med Res Methodol. 2020 Jun 17;20(1):160. doi: 10.1186/s12874-020-01041-8.
9
The role of real-world data in the development of treatment guidelines: a case study on guideline developers' opinions about using observational data on antibiotic prescribing in primary care.真实世界数据在治疗指南制定中的作用:以指南制定者对初级保健中使用抗生素处方观察数据的意见为例。
BMC Health Serv Res. 2019 Dec 5;19(1):942. doi: 10.1186/s12913-019-4787-5.
10
Clients' perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: a qualitative evidence synthesis.客户对通过移动设备获取的生殖、孕产妇、新生儿、儿童和青少年健康方面的定向数字通信的认知与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2019 Oct 14;10(10):CD013447. doi: 10.1002/14651858.CD013447.

本文引用的文献

1
Barriers and facilitators to the implementation of doctor-nurse substitution strategies in primary care: a qualitative evidence synthesis.基层医疗中实施医生-护士替代策略的障碍与促进因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2019 Apr 15;4(4):CD010412. doi: 10.1002/14651858.CD010412.pub2.
2
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.GRADE证据到决策(EtD)框架:一种用于做出明智医疗选择的系统且透明的方法。2:临床实践指南。
BMJ. 2016 Jun 30;353:i2089. doi: 10.1136/bmj.i2089.
3
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.GRADE证据到决策(EtD)框架:一种做出明智医疗选择的系统且透明的方法。1:引言。
BMJ. 2016 Jun 28;353:i2016. doi: 10.1136/bmj.i2016.
4
Health systems guidance appraisal--a critical interpretive synthesis.卫生系统指南评估——一项批判性诠释性综述
Implement Sci. 2016 Jan 22;11:9. doi: 10.1186/s13012-016-0373-y.
5
What matters to women: a systematic scoping review to identify the processes and outcomes of antenatal care provision that are important to healthy pregnant women.对女性重要的事项:一项系统性综述,旨在确定对健康孕妇而言重要的产前护理提供过程及结果。
BJOG. 2016 Mar;123(4):529-39. doi: 10.1111/1471-0528.13819. Epub 2015 Dec 24.
6
Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual).在卫生和社会干预决策中使用定性证据:一种评估定性证据综合结果可信度的方法(GRADE-CERQual)
PLoS Med. 2015 Oct 27;12(10):e1001895. doi: 10.1371/journal.pmed.1001895. eCollection 2015 Oct.
7
Promoting professional behaviour change in healthcare: what interventions work, and why? A theory-led overview of systematic reviews.促进医疗保健领域的职业行为改变:哪些干预措施有效,原因何在?基于理论的系统评价综述
BMJ Open. 2015 Sep 30;5(9):e008592. doi: 10.1136/bmjopen-2015-008592.
8
Health system context and implementation of evidence-based practices-development and validation of the Context Assessment for Community Health (COACH) tool for low- and middle-income settings.卫生系统背景与循证实践的实施——为低收入和中等收入环境开发并验证社区卫生情境评估(COACH)工具
Implement Sci. 2015 Aug 15;10:120. doi: 10.1186/s13012-015-0305-2.
9
I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventions.I-RREACH:一种用于提高研究人员、组织和社区在复杂干预措施中实施准备程度的参与和评估工具。
Implement Sci. 2015 May 4;10:64. doi: 10.1186/s13012-015-0257-6.
10
Optimizing the delivery of contraceptives in low- and middle-income countries through task shifting: a systematic review of effectiveness and safety.通过任务转移优化低收入和中等收入国家的避孕药具供应:有效性和安全性的系统评价
Reprod Health. 2015 Apr 1;12:27. doi: 10.1186/s12978-015-0002-2.